Vifor Fresenius Medical Care Renal Pharma
Clinical trials sponsored by Vifor Fresenius Medical Care Renal Pharma, explained in plain language.
-
New hope for kidney patients: drug safely lowers dangerous potassium levels
Disease control CompletedThis study tested a drug called patiromer in 262 Chinese adults with chronic kidney disease and high potassium levels. Participants took patiromer for 4 weeks, then some switched to placebo for 8 weeks to see if potassium stayed controlled. The goal was to manage potassium safely…
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug may scratch the itch for dialysis patients
Symptom relief CompletedThis study tested a drug called difelikefalin to see if it can reduce moderate-to-severe itching in Chinese adults on hemodialysis. 260 participants received either the drug or a placebo three times a week for 12 weeks. The main goal was to measure changes in itching intensity us…
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Symptom relief
Last updated Jun 26, 2026 15:36 UTC